MEGAN METHENY: Open Payments
NPI 1346882008 · STRATHAM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 38 payments from 9 companies in 2025. Trend: 2023 $55 · 2024 $81 · 2025 $957
Food & beverage: $761Education: $196
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $503 |
| ABBVIE INC. | 18 | $212 |
| Regeneron Healthcare Solutions, Inc. | 2 | $114 |
| Organon LLC | 6 | $35 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, NEMLUVIO, OPZELURA, TALTZ, Sotyktu.
Industry payments across NH — which companies pay providers there.
